Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 11, 1999

View Archived Issues

Novo Nordisk, Takeda will collaborate on marketing of antidiabetic drugs in Japan

Novel benzoxazine compounds for treating neurological and psychological disorders

Novel NSAIDs synthesized and evaluated at Ortho-McNeil

Structurally unique metabotropic glutamate receptor ligands disclosed by Pfizer

Inflazyme: Q2 1999 highlights

Bone Care gears up for launch of first product during Q4 1999

Licensing opportunity from NIH: NAT modulators for enhancing efficacy, reducing toxicity of drugs

Bayer submits amendment to ProMem NDA

Advanced Magnetics receives NIH grant to support research into new diagnostic approach

Argonex forms gene therapy joint venture with Rohm and Haas

PD-184352 inhibits growth of colon tumors in mice via interference with MAPK pathway

Visudyne filed for marketing approval with EMEA

PRAISE study will evaluate Merck drug's ability to prevent AD in patients with mild memory loss

Limonene analogue XR-3054 is a novel protein farnesyltransferase inhibitor

Ethical, LEK to collaborate on development of transdermal analgesic

Third-generation lentiviral vectors from Cell Genesys boast improved safety features

Protein farnesyltransferase inhibitors from Pfizer inhibit abnormal cell growth

New antifungal agents from SS Pharm. with more potent activity than fluconazole

Antiallergic quinoline compounds prepared and tested by Dainippon Ink & Chemicals

FDA further expands approved indications for Zocor

BioSpecifics Technologies announces positive preliminary results in Peyronie's disease therapy

Cytarabine analogue P-4055 has significantly higher antitumor potency; clinical trials recommended

Antiparkinsonian potential of 968, an active compound extracted from Chinese herbs

Phase II oral mucositis results promising; nonetheless, P&U withdraws from IB-367 collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...